1-161037786-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001113207.2(TSTD1):āc.337A>Gā(p.Lys113Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000412 in 1,551,690 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001113207.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSTD1 | NM_001113207.2 | c.337A>G | p.Lys113Glu | missense_variant | 4/4 | ENST00000423014.3 | NP_001106678.1 | |
TSTD1 | NM_001113206.2 | c.214A>G | p.Lys72Glu | missense_variant | 3/3 | NP_001106677.1 | ||
TSTD1 | NM_001113205.2 | c.*93A>G | 3_prime_UTR_variant | 3/3 | NP_001106676.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSTD1 | ENST00000423014.3 | c.337A>G | p.Lys113Glu | missense_variant | 4/4 | 2 | NM_001113207.2 | ENSP00000388293.2 | ||
ENSG00000270149 | ENST00000289779.7 | n.10+1094A>G | intron_variant | 2 | ENSP00000289779.4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000639 AC: 1AN: 156600Hom.: 0 AF XY: 0.0000120 AC XY: 1AN XY: 83012
GnomAD4 exome AF: 0.0000436 AC: 61AN: 1399430Hom.: 2 Cov.: 31 AF XY: 0.0000493 AC XY: 34AN XY: 690228
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | The c.337A>G (p.K113E) alteration is located in exon 4 (coding exon 4) of the TSTD1 gene. This alteration results from a A to G substitution at nucleotide position 337, causing the lysine (K) at amino acid position 113 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at